Infinimmune

Human-derived antibody medicines

Infinimmune is a biotech company in South San Francisco, United States, founded in 2022. It has raised $87.0M across 2 rounds, most recently a $75.0M Series A in August 2026.

Employees
1–10
Founded
2022
Business Model
B2B
Total Funding
$87.0M
Last Round
$75.0M Series AAug 2026
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 5 investors for this company. to use credits for reveals, or explore the API.

About

Infinimmune systematically surfaces and engineers the rare antibodies evolution has already proven in people and advances them into the clinic. The company holds the world's largest database of millions of paired heavy- and light-chain antibody sequences, sourced from a continuous pipeline of diverse healthy and diseased human donors. Using its Complete Human sequencing technology and Anthrobody library-on-B-cell platform, Infinimmune discovers fully paired, antigen-specific antibody sequences from up to 300 million B cells across 350+ targets, and applies its GLIMPSE antibody language model to optimize affinity, potency, and developability in as little as eight weeks.

Funding History

Data from Indexed.vcUpdated
Series ASeries AAug 2026
$75.0M

1 more funding event

  • Seed20224 investors

Funding: Seed through Series A. Amounts, valuations, and investors where available.

Investors

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

  • Cloud/Infrastructure ×1
  • Frontend ×1
  • Marketing & SEO ×1

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Companies in related industries

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Infinimmune on Indexed.vc
<a href="https://indexed.vc/companies/infinimmune"><img src="https://indexed.vc/api/badge/company/infinimmune" alt="Infinimmune on Indexed.vc" width="260" height="76" /></a>